CBS 2019
CBSMD教育中心
English

Congestive Heart Failure

科研文章

荐读文献

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study Good response to tolvaptan shortens hospitalization in patients with congestive heart failure Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead? HFpEF: From Mechanisms to Therapies Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure Respiratory Syncytial Virus and Associations With Cardiovascular Disease in Adults Heart failure with preserved ejection fraction: from mechanisms to therapies Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial

Clinical TrialFebruary 6, 2018, Volume 137, Issue 6

JOURNAL:Circulation Article Link

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study

M .Kosiborod, CVD-REAL Investigators and Study Group. Keywords: SGLT2 inhibitor; death; diabetes mellitus; heart failure; observational studies

FULL TEXT PDF